Curis | CRIS - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 12.04B 2.91B 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
CSL USD 2.16B 633M 2025-06
Curis USD 10.14M 10.14M 2025-06
Eli Lilly USD 5.28B 1.99B 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Takeda JPY 654.94B 26.55B 2025-12
TG Therapeutics USD 442.21M 242.7M 2026-03
Verastem USD 204.99M 67.28M 2025-12
Xoma USD 143.9M 7.68M 2024-06